Literature DB >> 19575332

Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.

R Baturone1, M J Soto, M Márquez, I Macías, M Montes de Oca, F Medina, N Chozas, S García-Pérez, J A Girón-González.   

Abstract

OBJECTIVE: A cross-sectional study of 30 patients with primary Sjögren's syndrome (pSS) was performed to analyse the health-related quality of life and its relationship with serum levels of macrophage- and lymphocyte-derived cytokines. PATIENTS AND METHODS: Health-related quality of life was evaluated using the 36-item Short Form Health Survey (SF-36). Serum levels of interleukin (IL)-1beta, IL-6, IL-10, tumour necrosis factor (TNF)-alpha, and gamma-interferon (gamma-INF) were analysed by a sandwich immunoassay-based protein array system.
RESULTS: Each of the eight scales of the SF-36 evaluating quality of life, as well as the physical composite score (PCS) and the mental composite score (MCS), showed a decrease in pSS patients. Similarly, patients with pSS showed significantly increased concentrations of each of the five cytokines analysed, when compared with the healthy control group (n = 20). In pSS patients, a significant negative correlation was detected between serum levels of IL-6 and the PCS of the SF-36. Those patients with concentrations of IL-6 higher than those of the healthy controls showed a significantly lower score in the dimensions of bodily pain and physical functioning, and in the PCS.
CONCLUSIONS: Patients with pSS showed increased levels of several macrophage- and lymphocyte-derived cytokines, indicating the existence of an immune activation state. Serum levels of one of these cytokines, IL-6, were correlated with poor quality of life in these individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575332     DOI: 10.1080/03009740902973821

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  17 in total

1.  Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome.

Authors:  Silvia Reina; Daniela Passafaro; Leonor Sterin-Borda; Enri Borda
Journal:  Inflammopharmacology       Date:  2012-03-23       Impact factor: 4.473

Review 2.  TRP Channels as Molecular Targets to Relieve Endocrine-Related Diseases.

Authors:  Yusheng Liu; Yihan Lyu; Hongmei Wang
Journal:  Front Mol Biosci       Date:  2022-04-28

3.  Uncovering potential single nucleotide polymorphisms, copy number variations and related signaling pathways in primary Sjogren's syndrome.

Authors:  Xuan Qi; Xi-Qin Wang; Lu Jin; Li-Xia Gao; Hui-Fang Guo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2011-06-01

Review 5.  What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?

Authors:  Cees G M Kallenberg; Arjan Vissink; Frans G M Kroese; Wayel H Abdulahad; Hendrika Bootsma
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

6.  Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report.

Authors:  Chiara Baldini; Laura Giusti; Federica Ciregia; Ylenia Da Valle; Camillo Giacomelli; Elena Donadio; Francesco Ferro; Sara Galimberti; Valentina Donati; Laura Bazzichi; Stefano Bombardieri; Antonio Lucacchini
Journal:  J Transl Med       Date:  2011-11-02       Impact factor: 5.531

7.  A five-year prospective study of fatigue in primary Sjögren's syndrome.

Authors:  Karstein Haldorsen; Ingvar Bjelland; Anne Isine Bolstad; Roland Jonsson; Johan Gorgas Brun
Journal:  Arthritis Res Ther       Date:  2011-10-13       Impact factor: 5.156

8.  Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome.

Authors:  Laiza Hombre Dias; Samira Tatiyama Miyamoto; Raquel Altoé Giovelli; Caerê Iamonde Maciel de Magalhães; Valeria Valim
Journal:  Adv Rheumatol       Date:  2021-05-29

9.  The joint subclinical elevation of CRP and IL-6 is associated with lower health-related quality of life in comparison with no elevation or elevation of only one of the biomarkers.

Authors:  Peter Garvin; Evalill Nilsson; Jan Ernerudh; Margareta Kristenson
Journal:  Qual Life Res       Date:  2015-07-21       Impact factor: 4.147

10.  Interferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells.

Authors:  Martha E Arellano-Garcia; Kaori Misuno; Simon D Tran; Shen Hu
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.